Comparison of Home-Based Oral Fluid Rapid HIV Self-Testing Versus Mail-in Blood Sample Collection or Medical/Community HIV Testing By Young Adult Black, Hispanic, and White MSM: Results from a Randomized Trial
Authors
Merchant, Roland C.Clark, Melissa A.
Liu, Tao
Romanoff, Justin
Rosenberger, Joshua G.
Bauermeister, Jose
Mayer, Kenneth H.
UMass Chan Affiliations
Center for Health Policy and Research, Commonwealth MedicineDepartment of Quantitative Health Sciences
Document Type
Journal ArticlePublication Date
2017-05-24Keywords
Clinical trialHIV testing
Men-who-have-sex-with-men
Young adult
Community-Based Research
Community Health and Preventive Medicine
Immune System Diseases
Virus Diseases
Metadata
Show full item recordAbstract
We aimed to determine in a randomized trial if young adult black, Hispanic, and white men-who-have-sex-with-men (YMSM) are more likely to complete home-based oral fluid rapid HIV self-testing than either mail-in blood sample collection or medical facility/community organization-based HIV testing. Stratified by race/ethnicity, participants were randomly assigned to use a free oral fluid rapid HIV self-test (n = 142), a free mail-in blood sample collection HIV test (n = 142), or be tested at a medical facility/community organization of their choice (n = 141). Of the 425 participants, completion of assigned test (66% oral fluid vs. 40% mail-in blood sample vs. 56% medical facility/community), willingness to refer (36% oral fluid vs. 20% mail-in blood sample vs. 26% medical facility/community), and legitimate referrals (58% oral fluid vs. 43% mail-in blood sample vs. 43% medical facility/community) were greater in the oral fluid rapid HIV self-test than the mail-in blood sample collection HIV test arm, but not the medical facility/community testing arm. There were no differences in assigned test completion by race/ethnicity. Although free home-based oral fluid rapid HIV self-testing showed moderate promise in facilitating HIV testing among black, Hispanic, and white YMSM, it did not lead to greater testing than directing these YMSM to medical facility/community HIV testing venues. ClinicalTrials.gov Identifier: NCT02369627.Source
AIDS Behav. 2017 May 24. doi: 10.1007/s10461-017-1802-x. Link to article on publisher's siteDOI
10.1007/s10461-017-1802-xPermanent Link to this Item
http://hdl.handle.net/20.500.14038/29151PubMed ID
28540562Related Resources
ae974a485f413a2113503eed53cd6c53
10.1007/s10461-017-1802-x